The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland — ...
Pfizer stockholders can get cash or one share of the combined company for each of their shares, but the aggregate amount of cash must range from $6 billion to $12 billion. The merger, which will ...
The U.S. drug giant Pfizer and its smaller rival Allergan have agreed to merge, creating the world's biggest pharmaceutical company by sales. The $160 billion deal is the largest example so far of a ...
U.S. companies will find it much harder to reduce their taxes by merging with foreign firms under new rules introduced by the Obama administration, and that's already throwing the fate of one big deal ...
The world's biggest pharmaceutical merger was called off today by Pfizer and Allergan, a company in Ireland. It's being called a victory for President Obama, who announced yesterday that actions by ...
This year is shaping up to possibly be the most transformative in Pfizer's storied history. Despite adding megacap Wyeth to the mix back in 2009, its $160 billion merger with Allergan is set to ...
Hillary Clinton blasted the merger of pharmaceutical giants Pfizer and Allergan Monday, despite the fact that Pfizer is a longtime supporter of Clinton causes. “For too long, powerful corporations ...
Allergan PLC's investors still don't appreciate the long-term value of Pfizer Inc. $155 billion acquisition of the company. That's the view of Nomura equity analyst Shibani Malhotra in a research note ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Yesterday I spoke on NECN about the deal and its effect on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results